PM02734
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PM02734, covering 2014-03-26 to 2014-03-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors [Phase 1]